[Progress in the study of plasma-drug concentration of imatinib for treatment of chronic myeloid leukemia]

Zhonghua Xue Ye Xue Za Zhi. 2012 Jan;33(1):69-70.
[Article in Chinese]
No abstract available

Publication types

  • Review

MeSH terms

  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Piperazines / pharmacokinetics*
  • Piperazines / therapeutic use
  • Pyrimidines / pharmacokinetics*
  • Pyrimidines / therapeutic use

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate